We are live on
!
Find out more
CT
Cambridge Trust Portfolio holdings
AUM
$2.64B
Turnover
15.41%
1-Year Est. Return
28.73%
This Fund
S&P 500
This Quarter
Est. Return
-13.22%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$2.28B
AUM Growth
-$571M
(-20%)
Cap. Flow
-$160M
Cap. Flow
% of AUM
-7.02%
Top 10 Holdings %
Top 10 Hldgs %
27.44%
Holding
985
New
54
Increased
140
Reduced
331
Closed
122
Avg Time Held
1.9
years
Top 10 Avg Time Held
2.6
years
Top 20 Avg Time Held
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$13.7M |
| 2 |
Coca-Cola
KO
|
+$10.7M |
| 3 |
CVS Health
CVS
|
+$9.84M |
| 4 |
Chart Industries
GTLS
|
+$4.3M |
| 5 |
Eaton
ETN
|
+$4.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$45.1M |
| 2 |
Apple
AAPL
|
+$17.6M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$15.8M |
| 4 |
Danaher
DHR
|
+$12.1M |
| 5 |
Meta Platforms (Facebook)
META
|
+$11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.07% |
| 2 | Financials | 16.12% |
| 3 | Healthcare | 14.36% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Miscellaneous | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
401
State Street US Sector Rotation ETF
XLSR
$1.1B
| $94K | ﹤0.01% |
2,461
-315
| -11% | -$13.1K |
2022 Q1
1 quarter
|
|
402
Medical Properties Trust
MPT
$1.88B
| $93K | ﹤0.01% |
6,135
| – | – |
2021 Q4
2 quarters
|
|
403
Vanguard FTSE All-World ex-US ETF
VEU
$67.6B
| $93K | ﹤0.01% |
1,870
-5,547
| -75% | -$297K |
2021 Q1
5 quarters
|
|
404
Gilead Sciences
GILD
$194B
| $92K | ﹤0.01% |
1,487
-87
| -6% | -$5.39K |
2021 Q4
2 quarters
|
|
405
Zebra Technologies
ZBRA
$17.8B
| $92K | ﹤0.01% |
313
-275
| -47% | -$95.8K |
2021 Q4
2 quarters
|
|
406
CRISPR Therapeutics
CRSP
$4.89B
| $91K | ﹤0.01% |
1,500
| – | – |
2021 Q4
2 quarters
|
|
407
Hexcel
HXL
$6.93B
| $91K | ﹤0.01% |
1,742
| – | – |
2021 Q4
2 quarters
|
|
408
Regeneron Pharmaceuticals
REGN
$82B
| $91K | ﹤0.01% |
153
| – | – |
2021 Q4
2 quarters
|
|
409
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.4B
| $90K | ﹤0.01% |
872
+29
| +3% | +$3.29K |
2021 Q4
2 quarters
|
|
|
DRE
410
DELISTED
Duke Realty Corp.
DRE
| $87K | ﹤0.01% |
1,585
+39
| +3% | +$2.13K |
2021 Q4
2 quarters
|
|
411
BHP
BHP
$214B
| $85K | ﹤0.01% |
1,506
+181
| +14% | +$11.2K |
2021 Q4
2 quarters
|
|
412
Helmerich & Payne
HP
$3.78B
| $85K | ﹤0.01% |
1,975
-210
| -10% | -$9.76K |
2021 Q4
2 quarters
|
|
413
Lamar Advertising Co
LAMR
$15.2B
| $85K | ﹤0.01% |
962
+489
| +103% | +$49.6K |
2022 Q1
1 quarter
|
|
414
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $84K | ﹤0.01% |
1,140
-69
| -6% | -$5.37K |
2021 Q4
2 quarters
|
|
415
Intuit
INTU
$88.5B
| $84K | ﹤0.01% |
219
-977
| -82% | -$405K |
2021 Q4
2 quarters
|
|
416
Tompkins Financial
TMP
$1.42B
| $84K | ﹤0.01% |
1,168
| – | – |
2021 Q4
2 quarters
|
|
417
Biogen
BIIB
$34.5B
| $81K | ﹤0.01% |
397
+62
| +19% | +$12.7K |
2021 Q4
2 quarters
|
|
418
iShares Global Clean Energy ETF
ICLN
$2.14B
| $81K | ﹤0.01% |
4,260
+750
| +21% | +$14.6K |
2021 Q4
2 quarters
|
|
419
iShares Core MSCI Europe ETF
IEUR
$9.4B
| $80K | ﹤0.01% |
1,776
+151
| +9% | +$7.46K |
2021 Q4
2 quarters
|
|
420
State Street SPDR S&P Insurance ETF
KIE
$546M
| $79K | ﹤0.01% |
2,075
| – | – |
2022 Q1
1 quarter
|
|
421
DELISTED
SunPower Corporation Common Stock
SPWR
| $79K | ﹤0.01% |
5,000
| – | – |
2021 Q4
2 quarters
|
|
422
Commerce Bancshares
CBSH
$8.06B
| $78K | ﹤0.01% |
1,448
| – | – |
2021 Q4
2 quarters
|
|
423
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.1B
| $78K | ﹤0.01% |
911
| – | – |
2021 Q4
2 quarters
|
|
424
Moderna
MRNA
$88.4B
| $78K | ﹤0.01% |
546
| – | – |
2021 Q3
3 quarters
|
|
425
National Grid
NGG
$80.9B
| $78K | ﹤0.01% |
1,305
-39
| -3% | -$2.58K |
2021 Q4
2 quarters
|
|
Similar funds
ZCM
CQS
SCM
AFIMH
DA
Cambridge Trust's Q2 2022 Portfolio in Review
As of Q2 2022, Cambridge Trust held 985 positions worth $2.28B, down 20% from $2.86B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Cambridge Trust withdrew a net $160M in Q2 2022, closing 122 positions and reducing 331 holdings. Its most notable exit was Paycom, an estimated $915K position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Cambridge Trust opened a new position in Chart Industries worth $4.21M.
- Cambridge Trust's largest Q2 2022 buy was Chart Industries: 25,166 shares worth $4.21M.
- Cambridge Trust added most to ExxonMobil in Q2 2022, an estimated $13.7M increase.
- Cambridge Trust's biggest Q2 2022 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $45.1M.
- Cambridge Trust fully exited Paycom in Q2 2022, selling an estimated $915K.
- Cambridge Trust's ten largest holdings make up 27% of its $2.28B portfolio in Q2 2022.
- Cambridge Trust opened 54 new positions and closed 122 in Q2 2022.
- Cambridge Trust's portfolio value fell 20% quarter-over-quarter to $2.28B.
Based on Cambridge Trust's 13F filing for Q2 2022, filed 16 Aug 2022.